Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy clinical trial (NCT00389155). Contact the study team or your healthcare provider for specific answers.

Question 2

How does vinflunine combined with gemcitabine compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy clinical trial (NCT00389155). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of vinflunine and gemcitabine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy clinical trial (NCT00389155). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy clinical trial (NCT00389155). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my cancer progresses while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy clinical trial (NCT00389155). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional tests or procedures I would need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy clinical trial (NCT00389155). Contact the study team or your healthcare provider for specific answers.

What this study is about